Compare Stocks → Your Money is Not Safe (From American Alternative) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:MBXTSE:ONCNYSEARCA:QPT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBXMicrobix BiosystemsC$0.34-2.9%C$0.38C$0.23▼C$0.47C$45.74M0.2870,814 shs21,500 shsONCOncolytics BiotechC$1.47+2.8%C$1.44C$1.20▼C$4.49C$110.87M1.4977,454 shs29,418 shsQPTAdvisorShares Q Portfolio Blended Allocation ETF$19.10+0.1%$19.10$18.63▼$27.54$1.91MN/A1,912 shs19,400 shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBXMicrobix Biosystems-1.47%-4.29%-9.46%-18.29%-12.99%ONCOncolytics Biotech-2.05%-2.72%+3.62%-13.86%-8.92%QPTAdvisorShares Q Portfolio Blended Allocation ETF0.00%0.00%0.00%0.00%0.00%At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMBXMicrobix BiosystemsN/AN/AN/AN/AN/AN/AN/AN/AONCOncolytics Biotech0.5878 of 5 stars3.50.00.00.01.10.00.0QPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMBXMicrobix Biosystems3.00BuyN/AN/AONCOncolytics Biotech3.00BuyC$6.00308.16% UpsideQPTAdvisorShares Q Portfolio Blended Allocation ETF0.00N/AN/AN/ACurrent Analyst RatingsLatest MTPH, MBX, QPT, KZA, and ONC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024ONCOncolytics BiotechRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOutperformC$3.00(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMBXMicrobix BiosystemsC$22.42M2.04C$0.08 per share4.13C$0.20 per share1.68ONCOncolytics BiotechN/AN/AC$0.35 per share4.22C$0.37 per shareN/AQPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMBXMicrobix BiosystemsC$3.72MC$0.0311.17∞N/A16.57%14.66%1.87%5/9/2024 (Estimated)ONCOncolytics Biotech-C$27.75M-C$0.41N/A∞N/AN/A-102.66%-55.47%5/3/2024 (Estimated)QPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/A0.00∞N/AN/AN/AN/AN/ALatest MTPH, MBX, QPT, KZA, and ONC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/7/2024Q4 2023ONCOncolytics Biotech-C$0.15-C$0.05+C$0.10-C$0.05N/AN/A2/14/2024Q1 2024MBXMicrobix BiosystemsN/AC$0.02+C$0.02C$0.02C$8.10 millionC$8.41 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMBXMicrobix BiosystemsN/AN/AN/AN/AN/AONCOncolytics BiotechN/AN/AN/AN/AN/AQPTAdvisorShares Q Portfolio Blended Allocation ETF$0.080.42%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMBXMicrobix Biosystems24.538.535.57ONCOncolytics Biotech1.549.018.86QPTAdvisorShares Q Portfolio Blended Allocation ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipMBXMicrobix Biosystems0.42%ONCOncolytics Biotech6.98%QPTAdvisorShares Q Portfolio Blended Allocation ETFN/AInsider OwnershipCompanyInsider OwnershipMBXMicrobix Biosystems14.07%ONCOncolytics Biotech6.24%QPTAdvisorShares Q Portfolio Blended Allocation ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableMBXMicrobix BiosystemsN/A136.55 millionN/ANot OptionableONCOncolytics Biotech2975.42 millionN/ANot OptionableQPTAdvisorShares Q Portfolio Blended Allocation ETFN/A100,000N/ANot OptionableMTPH, MBX, QPT, KZA, and ONC HeadlinesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsMicrobix BiosystemsTSE:MBXMicrobix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.Oncolytics BiotechTSE:ONCOncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.AdvisorShares Q Portfolio Blended Allocation ETFNYSEARCA:QPT Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
